Scientists identify potential biomarkers associated with positive immunotherapy response

FHS
June 26, 2023
6:05 pm

Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified potential new biomarkers that could indicate how someone diagnosed with metastatic melanoma will respond to immunotherapy treatment.

Glytec Simplifies Glycemic Management for Clinicians with Enhanced Epic EHR Integration

What You Should Know: Glytec, the only provider of cloud-based insulin management software across the continuum of care, today unveiled the latest version of its Glucommander®

August 2, 2023

Atara to file T cell immunotherapy in the US in 2024; RayzeBio closes $358M IPO

Atara Biotherapeutics said Tuesday that it plans to submit its T cell immunotherapy for approval in the US next year. The therapy was approved last

September 21, 2023

Emicizumab Safe, Effective, in Infants With Hemophilia A

SAN DIEGO — Administering emicizumab (Hemlibra) to previously untreated or minimally treated infants with severe hemophilia A without factor VIII inhibitors is effective and safe,

December 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.